Enovix Corporation (ENVX) concluded trading on Thursday at a closing price of $6.48, with 4.08 million shares of worth about $26.41 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -22.30% during that period and on May 08, 2025 the price saw a gain of about 4.85%. Currently the company’s common shares owned by public are about 191.72M shares, out of which, 162.13M shares are available for trading.
Stock saw a price change of 5.54% in past 5 days and over the past one month there was a price change of 18.68%. Year-to-date (YTD), ENVX shares are showing a performance of -40.39% which decreased to -33.74% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $5.27 but also hit the highest price of $18.68 during that period. The average intraday trading volume for Enovix Corporation shares is 5.77 million. The stock is currently trading 2.96% above its 20-day simple moving average (SMA20), while that difference is down -9.74% for SMA50 and it goes to -33.02% lower than SMA200.
Enovix Corporation (NASDAQ: ENVX) currently have 191.72M outstanding shares and institutions hold larger chunk of about 48.33% of that.
The stock has a current market capitalization of $1.24B and its 3Y-monthly beta is at 1.99. It has posted earnings per share of -$1.29 in the same period. It has Quick Ratio of 4.49 while making debt-to-equity ratio of 0.82. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ENVX, volatility over the week remained 5.22% while standing at 8.22% over the month.
Stock’s fiscal year EPS is expected to rise by 2.74% while it is estimated to increase by 9.15% in next year.
Coverage by The Benchmark Company stated Enovix Corporation (ENVX) stock as a Buy in their note to investors on July 22, 2024, suggesting a price target of $25 for the stock. On December 18, 2023, William Blair Initiated their recommendations, while on July 21, 2023, TD Cowen Downgrade their ratings for the stock with a price target of $20. Stock get a Buy rating from Canaccord Genuity on January 11, 2023.
